Prevalence of antineuronal antibodies in patients with encephalopathy of unknown etiology: Data from a nationwide registry in Korea

J Neuroimmunol. 2016 Apr 15:293:34-38. doi: 10.1016/j.jneuroim.2016.02.002. Epub 2016 Feb 21.

Abstract

We aimed to evaluate the prevalence of antineuronal antibodies in a nationwide cohort of patients with encephalopathy of unknown etiology. We screened 1699 patients with idiopathic encephalopathy who were referred from 70 hospitals across Korea for autoimmune synaptic and classic paraneoplastic antibodies. Those with cerebellar degeneration, sensory polyneuropathy or other paraneoplastic syndromes without encephalopathy were not included in this study. One-hundred and four patients (6.12%) had antibody-associated autoimmune encephalopathy. Autoimmune synaptic antibodies were identified in 89 patients (5.24%) and classic paraneoplastic antibodies were identified in 16 patients (0.94%). The patients with antibody-associated autoimmune encephalopathy comprised a small but significant portion of the total number of patients with encephalopathy of unknown cause.

Keywords: Autoimmune; Autoimmune synaptic antibody; Classic paraneoplastic antibody; Encephalopathy; Prevalence.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Age Factors
  • Autoantibodies / blood*
  • Autoantibodies / cerebrospinal fluid*
  • Brain Diseases / epidemiology*
  • Brain Diseases / etiology
  • Brain Diseases / immunology*
  • Cohort Studies
  • Female
  • Humans
  • Intracellular Signaling Peptides and Proteins
  • Male
  • Nerve Tissue Proteins / immunology*
  • Prevalence
  • Proteins / immunology
  • Receptors, N-Methyl-D-Aspartate / immunology
  • Registries*
  • Republic of Korea / epidemiology

Substances

  • Autoantibodies
  • Intracellular Signaling Peptides and Proteins
  • LGI1 protein, human
  • Nerve Tissue Proteins
  • Proteins
  • Receptors, N-Methyl-D-Aspartate